• Exchange: FN Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ChronTech Pharma AB

+ Add to Watchlist


0.0860 SEK 0.0070 8.86%

As of 07:37:44 ET on 08/20/2014.

Snapshot for ChronTech Pharma AB (CTEC)

Open: 0.0810 Day's Range: 0.0810 - 0.0900 Volume: 927,000
Previous Close: 0.0790 52wk Range: 0.0300 - 0.3200 1-Yr Rtn: +25.09%

Stock Chart for CTEC

No chart data available.
  • CTEC:SS 0.0860
  • 1D
  • 1M
  • 1Y
Interactive CTEC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CTEC

Current P/E Ratio (ttm) 0.9631
Estimated P/E(-) -
Relative P/E vs. OMX 0.0670
Earnings Per Share (ttm) 0.0820
Est. EPS -
Est. PEG Ratio -
Market Cap (M SEK) 22.21
Shares Outstanding (M) 281.17
30 Day Average Volume 585,490
Price/Book (mrq) 4.3035
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CTEC

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for CTEC

ChronTech Pharma AB is a biomedical company. The Company develops therapies for chronic diseases. The Company develops therapeutic DNA-vaccines drugs against chronic hepatitis C virus and hepatitis B-virus infections. ChronTech has also developed and further develops a patent pending new type of injection needle for a more effective uptake of DNA vaccines.

Anders VahlneCEO/Head:R&DAsa EkstrandChief Financial Officer
More Company Profile & Key Executives for CTEC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil